Mark Norton

Mark Norton, MPA, PAHM, director, informatics development, Health Management Corp.

At the Disease Management Association of America, Mark Norton, Director of Clinical Informatics Development at the Health Management Corporation division of Wellpoint, presented "Corroborating Disease Management Return On Investment Results through Analysis of Plausibility Indicators."

During the annual conference of the Disease Management Association of America (DMAA), Mark Norton, Director of Clinical Informatics Development for HMC, presented "Corroborating Disease Management Return on Investment Results through Analysis of Plausibility Indicators," in which HMC not only recognized and confirmed DMPC's approach to the technique, it is also pioneering expanding how the method is applied.Likewise, HMC's presentation has prompted DMPC to add alternative plausibility measures to the certification process.

"At HMC, we absolutely support documenting outcomes along a continuum to reinforce financial results," Norton said.

Mark Norton, MPA, PAHM, is the director of informatics development at Health Management Corp.He has worked in the managed health care industry for 17 years, with eight years of experience in the disease management sector.At HMC, Norton directs development of outcomes evaluation methodologies and manages the team that creates and maintains customer outcomes reporting platforms.

"What we tried to do is match up as close as we could an identical set of deliveries between a population that had access to the Baby Benefits Program and a population that did not have access to Baby Benefits, but that did have insurance through their health plan," explains Mark Norton, MPA, manager of health data for HMC."There were a number of different conditions and complications we matched for, including gestational diabetes, hypertension, multiple gestation, and problems with amniotic fluid.We also matched participants on the basis of geographic regions."

While most of the study participants lived in Virginia, Norton emphasizes that researchers tried to include participants representing diverse regions in both groups, including rural and metropolitan areas.Further, some adjustments were made for hospital cost arrangements that differed from one part of the state to another.

During the annual conference of the Disease Management Association of America (DMAA), Mark Norton, Director of Clinical Informatics Development for HMC, presented "Corroborating Disease Management Return on Investment Results through Analysis of Plausibility Indicators," in which HMC not only recognized and confirmed DMPC's approach to the technique, it is also pioneering expanding how the method is applied. Likewise, HMC's presentation has prompted DMPC to add alternative plausibility measures to the certification process.

"At HMC, we absolutely support documenting outcomes along a continuum to reinforce financial results," Norton said.

At the Disease Management Association of America, Mark Norton, Director of Clinical Informatics Development at the Health Management Corporation division of Wellpoint, presented "Corroborating Disease Management Return On Investment Results through Analysis of Plausibility Indicators.

During the annual conference of the Disease Management Association of America (DMAA), Mark Norton, Director of Clinical Informatics Development for HMC, presented "Corroborating Disease Management Return on Investment Results through Analysis of Plausibility Indicators," in which HMC not only recognized and confirmed DMPC's approach to the technique, but is also pioneering expanding how the method is applied.

Likewise, HMC's presentation has prompted DMPC to add alternative plausibility measures to the certification process."At HMC, we absolutely support documenting outcomes along a continuum to reinforce financial results," Norton said.